Anna A. Marusiak

873 total citations
16 papers, 256 citations indexed

About

Anna A. Marusiak is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Anna A. Marusiak has authored 16 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Anna A. Marusiak's work include Protein Degradation and Inhibitors (4 papers), Melanoma and MAPK Pathways (4 papers) and Ubiquitin and proteasome pathways (3 papers). Anna A. Marusiak is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Melanoma and MAPK Pathways (4 papers) and Ubiquitin and proteasome pathways (3 papers). Anna A. Marusiak collaborates with scholars based in Poland, United States and United Kingdom. Anna A. Marusiak's co-authors include John Brognard, Natalie L. Stephenson, Eleanor W. Trotter, Shameem Fawdar, Andrew Hudson, Dominika Nowis, Crispin Miller, Yaoyong Li, Dagmara Dymerska and Bohdan Waszkowycz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Anna A. Marusiak

15 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna A. Marusiak Poland	9	192	82	70	43	31	16	256
Brian T. Golitz United States	7	213 1.1×	77 0.9×	59 0.8×	28 0.7×	21 0.7×	16	276
G. Tjitske Los-de Vries Netherlands	3	187 1.0×	86 1.0×	62 0.9×	63 1.5×	34 1.1×	5	277
Charina Ortega United States	3	220 1.1×	71 0.9×	31 0.4×	26 0.6×	19 0.6×	4	294
Shiyi Yu China	12	257 1.3×	97 1.2×	67 1.0×	28 0.7×	33 1.1×	21	335
Xingling Zheng China	9	322 1.7×	89 1.1×	95 1.4×	19 0.4×	38 1.2×	12	431
Van T. Hoang United States	12	244 1.3×	114 1.4×	106 1.5×	27 0.6×	37 1.2×	25	362
Elizabeth McNeil United States	4	152 0.8×	86 1.0×	44 0.6×	26 0.6×	21 0.7×	6	221
Mike Berger United States	2	284 1.5×	53 0.6×	40 0.6×	45 1.0×	44 1.4×	3	344
Wai Wong United States	4	284 1.5×	71 0.9×	44 0.6×	43 1.0×	58 1.9×	5	365
Aurélie Dumont France	6	149 0.8×	80 1.0×	53 0.8×	34 0.8×	43 1.4×	9	229

Countries citing papers authored by Anna A. Marusiak

Since Specialization

Citations

This map shows the geographic impact of Anna A. Marusiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna A. Marusiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna A. Marusiak more than expected).

Fields of papers citing papers by Anna A. Marusiak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna A. Marusiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna A. Marusiak. The network helps show where Anna A. Marusiak may publish in the future.

Co-authorship network of co-authors of Anna A. Marusiak

This figure shows the co-authorship network connecting the top 25 collaborators of Anna A. Marusiak. A scholar is included among the top collaborators of Anna A. Marusiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna A. Marusiak. Anna A. Marusiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bergman, K., Eric Lindberg, Carolyn C. Woodroofe, et al.. (2025). Discovery of potent and selective PROTACs for the protein kinase LZK for the treatment of head and neck cancer. Journal of Biological Chemistry. 301(5). 108452–108452. 1 indexed citations

Sas, Zuzanna, Marcin Kałek, Karolina Szczepanowska, et al.. (2025). Profiling polyamine–protein interactions in live cells through photoaffinity labeling. RSC Chemical Biology. 6(11). 1787–1796.

Sabbasani, Venkata R., Pedro Torres‐Ayuso, Katarzyna Wróbel, et al.. (2024). Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC. Journal of Medicinal Chemistry. 67(17). 15012–15028. 5 indexed citations

Marusiak, Anna A., et al.. (2024). Protocols for Co-Culture Phenotypic Assays with Breast Cancer Cells and THP-1-Derived Macrophages. Journal of Mammary Gland Biology and Neoplasia. 29(1). 4–4. 7 indexed citations

Dymerska, Dagmara & Anna A. Marusiak. (2023). Drivers of cancer metastasis – Arise early and remain present. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(2). 189060–189060. 8 indexed citations

Torres‐Ayuso, Pedro, Meghri Katerji, Venkata R. Sabbasani, et al.. (2023). PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Cell chemical biology. 31(2). 326–337.e11. 6 indexed citations

Wysocki, Piotr, et al.. (2023). lncRNA DIRC3 regulates invasiveness and insulin-like growth factor signaling in thyroid cancer cells. Endocrine Related Cancer. 30(8). 2 indexed citations

Marusiak, Anna A., et al.. (2022). Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease. Cancer Letters. 547. 215775–215775. 21 indexed citations

Dymerska, Dagmara, et al.. (2021). MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance. Cell Death and Disease. 12(12). 1111–1111. 20 indexed citations

10.

Kędzierska, Hanna, et al.. (2021). Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors. Cancer Letters. 507. 13–25. 25 indexed citations

11.

Cunningham, Debbie L., Adil R. Sarhan, Andrew J. Creese, et al.. (2020). Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study. Scientific Reports. 10(1). 7950–7950. 9 indexed citations

12.

Marusiak, Anna A., Michał Łaźniewski, Hanna Kędzierska, et al.. (2018). Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells. Oncogene. 38(15). 2860–2875. 17 indexed citations

13.

Stephenson, Natalie L., Pedro Torres‐Ayuso, Anna A. Marusiak, et al.. (2016). Somatically mutated ABL 1 is an actionable and essential NSCLC survival gene. EMBO Molecular Medicine. 8(2). 105–116. 20 indexed citations

14.

Marusiak, Anna A., Willy Hugo, Eleanor W. Trotter, et al.. (2014). Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors. Nature Communications. 5(1). 3901–3901. 63 indexed citations

15.

Marusiak, Anna A., Willy Hugo, Eleanor W. Trotter, et al.. (2014). 76 Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors. European Journal of Cancer. 50. 29–30. 1 indexed citations

16.

Fawdar, Shameem, Eleanor W. Trotter, Yaoyong Li, et al.. (2013). Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer. Proceedings of the National Academy of Sciences. 110(30). 12426–12431. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact